PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Kapo Saukkonen
Jaana Hagström
Harri Mustonen
Anne Juuti
Stig Nordling
Pauliina Kallio
Kari Alitalo
Hanna Seppänen
Caj Haglund
机构：
[1] University of Helsinki and Helsinki University Hospital,Department of Surgery
[2] University of Helsinki,Research Programs Unit, Translational Cancer Biology
[3] University of Helsinki and Helsinki University Hospital,Department of Pathology, Haartman Institute and HUSLAB
来源：
BMC Cancer | / 16卷
关键词：
Pancreatic ductal adenocarcinoma; Beta-catenin; PROX1; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
    Saukkonen, Kapo
    Hagstrom, Jaana
    Mustonen, Harri
    Juuti, Anne
    Nordling, Stig
    Kallio, Pauliina
    Alitalo, Kari
    Seppanen, Hanna
    Haglund, Caj
    BMC CANCER, 2016, 16
  • [2] Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma
    Kantheti, Havish S.
    Hale, Michael A.
    Pal Choudhuri, Shreoshi
    Huang, Huocong
    Wang, Xu-dong
    Zolghadri, Yalda
    Innamorati, Giulio
    Manikonda, Sai Prasada Rao
    Reddy, Naviya
    Reddy, Sarthak
    Kollipara, Rahul K.
    Lumani, Valbona
    Girard, Luc
    Bezrukov, Yakov
    Demenkov, Pavel
    Macdonald, Raymond J.
    Brekken, Rolf A.
    Yu, Yonghao
    Wilkie, Thomas M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [3] Candidate diagnostic and prognostic markers for pancreatitis and pancreatic ductal adenocarcinoma
    Wilkie, Thomas M.
    Kantheti, Havish
    FASEB JOURNAL, 2022, 36
  • [4] Comparison of Prognostic Markers for Patients' Prognosis in Advanced Pancreatic Ductal Adenocarcinoma
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Watanabe, Ko
    Sugimoto, Mitsuru
    Waragai, Yuichi
    Kikuchi, Hitomi
    Asama, Hiroyuki
    Takasumi, Mika
    Ohira, Hiromasa
    GASTROENTEROLOGY, 2016, 150 (04) : S324 - S324
  • [5] Quantitative phase imaging of stromal prognostic markers in pancreatic ductal adenocarcinoma
    Fanous, Michael
    Keikhosravi, Adib
    Kajdacsy-Balla, Andre
    Eliceiri, Kevin
    Popescu, Gabriel
    BIOMEDICAL OPTICS EXPRESS, 2020, 11 (03) : 1354 - 1364
  • [6] Prox1 is a critical regulator of pancreatic development and homeostasis
    Sosa-Pineda, Beatriz
    Kilic, Gamze
    Sirma, Sema
    Oliver, Guillermo
    Grosveld, Gerard
    DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 415 - 415
  • [7] Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis
    Zhang, Zhipeng
    Sun, Weijia
    Zeng, Zhijun
    Lu, Yebin
    ACTA BIOCHIMICA POLONICA, 2022, 69 (02) : 327 - 333
  • [8] Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers
    El Kaoutari, Abdessamad
    Fraunhoffer, Nicolas A.
    Camoin, Luc
    Berthois, Yolande
    Gayet, Odile
    Roques, Julie
    Bigonnet, Martin
    Bongrain, Claire
    Ciccolini, Joseph
    Iovanna, Juan L.
    Dusetti, Nelson J.
    Soubeyran, Philippe
    EBIOMEDICINE, 2023, 92
  • [9] Prognostic markers in pancreatic ductal adenocarcinomas
    Hezel, Aram F.
    Bardeesy, Nabeel
    CANCER BIOLOGY & THERAPY, 2008, 7 (09) : 1361 - 1362
  • [10] The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma
    Agnihotri, Neha S.
    Astekar, Madhusudan
    JOURNAL OF EXPERIMENTAL THERAPEUTICS AND ONCOLOGY, 2018, 12 (03) : 171 - 184
12345